Cardiac and Metabolic Effects of Dapagliflozin in the Failing Fontan Circulation: a Phase II, Prospective, Double-Blind Study
Latest Information Update: 15 Jan 2025
Price :
$35 *
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 15 Jan 2025 New trial record